Imported-post
-
Interview: Interventions and Other Suicide Prevention Measures Employed or Adapted in the Context of COVID-19
Psychiatry Advisor spoke with VUSN professor Susan (Susie) Adams, PhD, PMHNP-BC, FAANP, FAAN, recently as she co-authored a paper regarding the role of primary care providers in suicide prevention during the pandemic. Read MoreMarch 4, 2021
-
John Dowlen, VUSN FNP Alumnus, hired at CHI Memorial Medical Group (TN)
CHI Memorial Medical group announces John Dowlen, FNP-C, has joined CHI Memorial Family Practice Associates – Soddy-Daisy. Mr. Dowlen is certified in basic life support as well as nonviolent crisis intervention. He’s also an ordained minister. He... Read MoreMarch 4, 2021
-
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine.... Read MoreMarch 4, 2021
-
Chikungunya antibody identified at VUMC moves forward
Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. Read MoreMarch 4, 2021
-
Love of Hebrew and Yiddish leads Allison Schachter to hidden stories of women authors
Allison Schachter, an associate professor of Jewish studies, English, and Russian and East European studies, developed a new theory about the role of women who made lasting and meaningful contributions to Jewish culture and history in the late nineteenth and early twentieth centuries. Read MoreMarch 2, 2021
-
Photonics discovery portends dramatic efficiencies in silicon chips
A team led by Vanderbilt engineers has achieved the ability to transmit two different types of optical signals across a single chip at the same time. The breakthrough heralds a potentially dramatic increase in the volume of data a silicon chip can transmit over any period of time. With this project, the research team moved... Read MoreMarch 1, 2021
-
Gene network for leukemia factor
A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment. Read MoreFebruary 4, 2021
-
Cancer Institute grant funds new integrated approach to early lung cancer detection
Vanderbilt researchers have received a National Cancer Institute grant to develop a novel, integrative approach to detect early signs of lung cancer. The four-year project builds on a related, recent study that established the value of using three separate measures—structural imaging, a protein marker and information available from electronic health records—to predict lung cancer in... Read MoreJanuary 22, 2021
-
Study finds genetic clues to pneumonia risk and COVID-19 disparities
Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences. Read MoreJanuary 21, 2021
-
NIH grant bolsters research on heart disease, cholesterol
Thanks to major funding from the National Institutes of Health (NIH), researchers at Vanderbilt University Medical Center have made major inroads in understanding how high-density lipoprotein (HDL), commonly known as good cholesterol, in some cases may... Read MoreJanuary 21, 2021